348 related articles for article (PubMed ID: 7474110)
21. CD4 modulation of noninfected human T lymphocytes by HIV-1 envelope glycoprotein gp120: contribution to the immunosuppression seen in HIV-1 infection by induction of CD4 and CD3 unresponsiveness.
Theodore AC; Kornfeld H; Wallace RP; Cruikshank WW
J Acquir Immune Defic Syndr (1988); 1994 Sep; 7(9):899-907. PubMed ID: 7914230
[TBL] [Abstract][Full Text] [Related]
22. Synergistic inhibition of human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion and infection by an antibody to CD4 domain 2 in combination with anti-gp120 antibodies.
Burkly L; Mulrey N; Blumenthal R; Dimitrov DS
J Virol; 1995 Jul; 69(7):4267-73. PubMed ID: 7769687
[TBL] [Abstract][Full Text] [Related]
23. Lysis of CD4+ T cells expressing HIV-1 gag peptides by gag-specific CD8+ cytotoxic T cells.
Salerno-Gonçalves R; Lu W; Achour A; Andrieu JM
Immunol Lett; 1998 Dec; 64(2-3):71-7. PubMed ID: 9870657
[TBL] [Abstract][Full Text] [Related]
24. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells.
Boasso A; Herbeuval JP; Hardy AW; Anderson SA; Dolan MJ; Fuchs D; Shearer GM
Blood; 2007 Apr; 109(8):3351-9. PubMed ID: 17158233
[TBL] [Abstract][Full Text] [Related]
25. Human immunodeficiency virus type 1 glycoprotein 120-specific T lymphocytes provide intermolecular help for anti-CD4 autoantibody production in exposed uninfected subjects.
Furci L; Beretta A; Siccardi A; Lazzarin A; Confetti C; Magnani Z; Scarpellini P; Lopalco L; Burastero SE
AIDS Res Hum Retroviruses; 1997 Nov; 13(17):1461-9. PubMed ID: 9390745
[TBL] [Abstract][Full Text] [Related]
26. Lysis of human immunodeficiency virus type 1 antigen-expressing cells by CD4 and CD8 T cells ex vivo.
Heinkelein M; Euler-König I; Klinker H; Rückle-Lanz H; Jassoy C
J Infect Dis; 1996 Jul; 174(1):209-13. PubMed ID: 8655997
[TBL] [Abstract][Full Text] [Related]
27. Fusion of human B cell lines with HIV-1 envelope-expressing T cells is enhanced by antigen-specific Ig receptors. Possible mechanism for elimination of gp120-specific B cells in vivo.
Golding H; Dimitrov DS; Blackburn R; Manischewitz J; Blumenthal R; Golding B
J Immunol; 1993 Mar; 150(6):2506-16. PubMed ID: 7680694
[TBL] [Abstract][Full Text] [Related]
28. HIV-1 gp120 and anti-gp120 induce reversible unresponsiveness in peripheral CD4 T lymphocytes.
Liegler TJ; Stites DP
J Acquir Immune Defic Syndr (1988); 1994 Apr; 7(4):340-8. PubMed ID: 7907660
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group.
Corey L; McElrath MJ; Weinhold K; Matthews T; Stablein D; Graham B; Keefer M; Schwartz D; Gorse G
J Infect Dis; 1998 Feb; 177(2):301-9. PubMed ID: 9466515
[TBL] [Abstract][Full Text] [Related]
30. Soluble CD4-PE40 is cytotoxic for a transfected mammalian cell line stably expressing the envelope protein of human immunodeficiency virus (HIV-1), and cytotoxicity is variably inhibited by the sera of HIV-1-infected patients.
Pitts TW; Bohanon MJ; Leach MF; McQuade TJ; Marschke CK; Merritt JA; Wierenga W; Nicholas JA
AIDS Res Hum Retroviruses; 1991 Sep; 7(9):741-50. PubMed ID: 1742081
[TBL] [Abstract][Full Text] [Related]
31. Defective killing activity against gp120/41-expressing human erythroleukaemic K562 cell line by monocytes and natural killer cells from HIV-infected individuals.
Ahmad A; Menezes J
AIDS; 1996 Feb; 10(2):143-9. PubMed ID: 8838701
[TBL] [Abstract][Full Text] [Related]
32. Monocyte-mediated lysis of HIV-infected tumor cells.
Debs RJ; Krowka J; Stites D; Brunette EN; Düzgünes N; Philip R
AIDS Res Hum Retroviruses; 1990 Aug; 6(8):1005-9. PubMed ID: 1699572
[TBL] [Abstract][Full Text] [Related]
33. HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens.
Wilson SE; Habeshaw JA; Addawe MA; Hounsell EF; Oxford JS
AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1313-24. PubMed ID: 9339848
[TBL] [Abstract][Full Text] [Related]
34. Full-length recombinant CD4 and recombinant gp120 inhibit fusion between HIV infected macrophages and uninfected CD4-expressing T-lymphoblastoid cells.
Crowe SM; Mills J; Kirihara J; Boothman J; Marshall JA; McGrath MS
AIDS Res Hum Retroviruses; 1990 Aug; 6(8):1031-7. PubMed ID: 1977427
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of HSV-1-specific cytotoxic T lymphocytes by recombinant-derived gp120 of HIV-1.
Schmid DS; Thieme ML; Ridgeway MR; Mawle AC
Viral Immunol; 1992; 5(4):249-56. PubMed ID: 1361737
[TBL] [Abstract][Full Text] [Related]
36. Human immunodeficiency virus type 1 replication, immune activation, and circulating cytotoxic T cells against uninfected CD4+ T cells.
Kottilil S; Gamberg J; Bowmer I; Trahey J; Howley C; Gallant M; Grant M
J Clin Immunol; 2000 May; 20(3):175-86. PubMed ID: 10941825
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of human immunodeficiency virus type 1 gp120 presentation to CD4 T cells by antibodies specific for the CD4 binding domain of gp120.
Hioe CE; Tuen M; Chien PC; Jones G; Ratto-Kim S; Norris PJ; Moretto WJ; Nixon DF; Gorny MK; Zolla-Pazner S
J Virol; 2001 Nov; 75(22):10950-7. PubMed ID: 11602735
[TBL] [Abstract][Full Text] [Related]
38. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
39. Early activation events render T cells susceptible to HIV-1-induced syncytia formation. Role of protein kinase C.
Mohagheghpour N; Chakrabarti R; Stein BS; Gowda SD; Engleman EG
J Biol Chem; 1991 Apr; 266(11):7233-8. PubMed ID: 1826686
[TBL] [Abstract][Full Text] [Related]
40. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
